News

Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.

 

dairy cows in barn eating hay

Mycobacterium Cell Wall Fraction (MCWF) Demonstrates Beneficial Efficacy in Dairy Cattle

NovaVive made two presentations at the World Buiatrics Congress in Sapporo, Japan today. Both presentations highlighted efficacy of MCWF in mature dairy cattle. More research is required, but these results are very promising.

head shot of Mark Hill

NovaVive Inc. Signs AABEX Animal Health to Provide U.S. Marketing Services

NovaVive Inc. has signed a marketing services agreement with AABEX Animal Health for the U.S.A. AABEX is a new animal health sales and marketing company founded by Mark Hill, a seasoned industry professional from Merial Ltd.

Dr. Jeannette Kelly with dog and sign that reads last chemo treatment

Immunocidin® Demonstrates an Acceptable Safety Profile Following Intravenous Administration in Dogs and Cats with Various Malignancies

Dr. Jeannette Kelly, veterinary oncologist with Veterinary Cancer Care, presented data from a study of multiple IV administrations of Immunocidin® in dogs and cats with various malignancies at the ACVIM Forum last week.

OMRI Listed seal

Amplimune® Receives US OMRI Listing for Use in Organic Cattle Production

Amplimune®, our immunotherapeutic for calf scours, has received an Organic Materials Review Institute (OMRI) Listing in the U.S.A. This means that Amplimune can be used in compliance with the USDA National Organic Program.

close-up of horse's eye post-treatment

Iowa State University College of Veterinary Medicine to Conduct a Study with Immunocidin® Equine in Two Types of Cancer

NovaVive's Immunocidin® Equine anticancer immunotherapeutic for horses will be evaluated in a clinical study at Iowa State University (ISU) College of Veterinary Medicine in sarcoids and squamous cell carcinoma.

mare and foal

Settle®, an Antibiotic Alternative for Treating Equine Endometritis, is Now Approved for Sale in New Zealand

NovaVive's immunotherapeutic for the treatment of equine endometritis, Settle®, has been approved for sale to New Zealand veterinarians by the NZ regulator. It was previously approved for sale in the U.S. and Australia.

Sign up to stay up-to-date with NovaVive news.